Wojciech Szczeklik Selected Research

Plasmapheresis

1/2016	Effectiveness of plasmapheresis in ANCA clearance in patients with ANCA-associated vasculitides.
8/2013	Supportive therapy for a patient with toxic epidermal necrolysis undergoing plasmapheresis.
1/2013	Complications in patients treated with plasmapheresis in the intensive care unit.
6/2010	Beneficial therapeutic effect of plasmapheresis after unsuccessful treatment with corticosteroids in two patients with severe toxic epidermal necrolysis.
4/2010	[Plasmapheresis in intensive therapy unit].
4/2008	Acute respiratory failure in patients with Guillain-Barré syndrome and myasthenic crisis treated with plasmapheresis in the intensive care unit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wojciech Szczeklik Research Topics

Disease

14	COVID-19 05/2022 - 01/2020
14	Critical Illness (Critically Ill) 03/2022 - 01/2013
13	Sepsis (Septicemia) 11/2021 - 01/2013
11	Hemorrhage 01/2022 - 09/2010
10	Myocardial Infarction 03/2022 - 04/2003
6	Frailty 03/2022 - 01/2019
6	Asthma (Bronchial Asthma) 12/2019 - 09/2002
5	Inflammation (Inflammations) 02/2022 - 09/2002
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 11/2008
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2014
5	Atherosclerosis 09/2021 - 12/2003
5	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2020 - 02/2013
5	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2019 - 11/2011
4	Vasculitis (Vasculitides) 05/2022 - 01/2011
4	Stroke (Strokes) 03/2022 - 01/2016
4	Atrial Fibrillation 03/2022 - 12/2010
4	Thrombosis (Thrombus) 01/2022 - 09/2008
4	Abdominal Aortic Aneurysm 11/2021 - 01/2016
4	Coronary Disease (Coronary Heart Disease) 11/2020 - 03/2010
4	Churg-Strauss Syndrome (Allergic Angiitis) 11/2019 - 01/2010
3	Hypotension (Low Blood Pressure) 01/2022 - 12/2020
3	Infections 01/2022 - 01/2017
3	Neoplasms (Cancer) 11/2021 - 12/2019
3	Myocardial Ischemia (Ischemic Heart Diseases) 06/2021 - 03/2014
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2019
3	Shock 01/2018 - 01/2013
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2017 - 01/2014
3	Stevens-Johnson Syndrome (Lyell's Syndrome) 08/2013 - 06/2010
3	Guillain-Barre Syndrome 01/2013 - 04/2008
3	Thrombotic Thrombocytopenic Purpura 04/2010 - 10/2005
2	Death (Near-Death Experience) 03/2022 - 12/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2022
2	Heart Failure 01/2022 - 12/2020
2	Venous Thromboembolism 01/2022 - 01/2018
2	Pain (Aches) 10/2021 - 01/2018
2	Peripheral Arterial Disease 02/2021 - 01/2019
2	Septic Shock (Toxic Shock Syndrome) 01/2021 - 01/2013
2	Respiratory Insufficiency (Respiratory Failure) 01/2020 - 04/2008
2	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 04/2003
2	Myasthenia Gravis 01/2013 - 04/2010
2	Eosinophilia 10/2012 - 01/2011
2	Respiratory Hypersensitivity 01/2003 - 09/2002
2	Pneumonia (Pneumonitis) 01/2003 - 09/2002
1	Bundle-Branch Block (Fascicular Block) 03/2022
1	Hypovolemia 02/2022
1	Diarrhea 01/2022
1	Hemorrhagic Stroke 01/2022

Drug/Important Bio-Agent (IBA)

8	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2022 - 01/2011
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 04/2003
5	TroponinIBA 03/2022 - 03/2014
5	AntibodiesIBA 01/2020 - 04/2003
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
4	LeukotrienesIBA 01/2018 - 09/2002
4	ProstaglandinsIBA 03/2010 - 09/2002
3	omega-Chloroacetophenone (Mace)IBA 03/2022 - 04/2018
3	Dabigatran FDA Link 01/2022 - 01/2018
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 08/2004
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2014 - 11/2008
3	ChemokinesIBA 02/2013 - 01/2011
2	Tranexamic Acid (AMCA)FDA Link 01/2022 - 01/2022
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2022 - 01/2022
2	factor V LeidenIBA 11/2020 - 01/2004
2	Troponin T (Troponin T1)IBA 01/2018 - 03/2014
2	ThromboxanesIBA 01/2018 - 01/2016
2	Biological ProductsIBA 01/2016 - 01/2015
2	GadoliniumIBA 01/2015 - 01/2011
2	EicosanoidsIBA 10/2013 - 09/2002
2	Interleukin-5 (Interleukin 5)IBA 10/2012 - 09/2002
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2008 - 10/2005
2	Clopidogrel (Plavix)FDA Link 09/2008 - 10/2005
2	thiamine triphosphorate (TTP)IBA 09/2008 - 10/2005
1	fibrin fragment D (D-dimer)IBA 05/2022
1	Hemostatics (Antihemorrhagics)IBA 05/2022
1	Cystatin CIBA 02/2022
1	Starch (Cornstarch)IBA 02/2022
1	Crystalloid SolutionsIBA 02/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	CreatinineIBA 01/2022
1	Opiate AlkaloidsIBA 01/2022

Therapy/Procedure

12	Critical Care (Surgical Intensive Care) 03/2022 - 01/2018
9	Therapeutics 02/2022 - 10/2005
8	Length of Stay 02/2022 - 10/2017
6	Artificial Respiration (Mechanical Ventilation) 01/2022 - 04/2008
6	Plasmapheresis 01/2016 - 04/2008
5	Renal Replacement Therapy (Therapies, Renal Replacement) 05/2020 - 12/2014
4	Vascular Surgical Procedures 02/2021 - 01/2018
3	Plasma Exchange 01/2020 - 01/2012
3	Neoadjuvant Therapy 01/2020 - 01/2019
3	Resuscitation 01/2018 - 01/2013
3	Extracorporeal Membrane Oxygenation 01/2018 - 01/2014
2	Activities of Daily Living (ADL) 03/2022 - 01/2022
2	Perioperative Care 01/2022 - 11/2021
2	Surgical Amputation (Amputations) 01/2022 - 01/2018
2	Mechanical Ventilators (Ventilator) 01/2022 - 10/2017
2	Blood Transfusion (Blood Transfusions) 01/2021 - 01/2021
2	Continuous Renal Replacement Therapy 02/2020 - 12/2014
2	Cystectomy 01/2020 - 12/2019
1	Perioperative Period 01/2022
1	Terminal Care (Care, Terminal) 01/2022